Interleukin-6: a comprehensive review.
Lotz
M
M
Department of Medicine, University of California, San Diego, La Jolla 92093-0663, USA.
D000210:Acute-Phase Reaction / Q000503:physiopathology; D000818:Animals; D015703:Antigens, CD / Q000737:chemistry / Q000187:drug effects / Q000502:physiology; D001327:Autoimmune Diseases / Q000503:physiopathology; D001402:B-Lymphocytes / Q000187:drug effects; D001862:Bone Resorption / Q000503:physiopathology; D002454:Cell Differentiation / Q000187:drug effects; D002986:Clinical Trials as Topic; D005786:Gene Expression Regulation; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007239:Infections / Q000503:physiopathology; D015850:Interleukin-6 / Q000737:chemistry / Q000172:deficiency / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D051379:Mice; D009196:Myeloproliferative Disorders / Q000503:physiopathology; D009363:Neoplasm Proteins / Q000502:physiology; D009369:Neoplasms / Q000503:physiopathology / Q000628:therapy; D009374:Neoplasms, Experimental / Q000628:therapy; D015213:Neuroimmunomodulation / Q000187:drug effects; D011828:Radiation Chimera; D018123:Receptors, Interleukin / Q000737:chemistry / Q000187:drug effects / Q000502:physiology; D019947:Receptors, Interleukin-6; D015398:Signal Transduction / Q000502:physiology; D013601:T-Lymphocytes / Q000378:metabolism; D000093242:Interleukin-6 Inhibitors
D015703:Antigens, CD; D007155:Immunologic Factors; D015850:Interleukin-6; D009363:Neoplasm Proteins; D018123:Receptors, Interleukin; D019947:Receptors, Interleukin-6; D000093242:Interleukin-6 Inhibitors